Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario-Reference-Cited by-同舟云学术

Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario

Published:2019-10 Issue: Volume:142 Page:26-34
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Rossi Giovanni,Pezzuto Aldo,Sini Claudio,Tuzi Alessandro,Citarella Fabrizio^ORCID,McCusker Michael G.^ORCID,Nigro Olga,Tanda Enrica,Russo Alessandro^ORCID

Funder

Borsa FSE XXXII ciclo Unime

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference78 articles.

1. Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors;Ahmed;OncoImmunology,2018

2. Impact of baseline steroids on efficacy of programmed cell Death-1 and programmed death-ligand 1 blockade in patients with non–Small-Cell lung Cancer;Arbour;J. Clin. Oncol.,2018

3. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors;Awadalla;J. Immunother. Cancer,2019

4. INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study;Bersanelli;Immunotherapy,2018

5. Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon;Cárcer;ISME J.,2010

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Combination of Therapeutic Approaches in Advanced NSCLC with EGFR Activating Mutations;Targets;2024-09-07

2. Immunotherapy Improves the Survival of Stage 4 Non–Small Cell Lung Cancer Patients at the US Population Level: The Real‐World Evidence;The Clinical Respiratory Journal;2024-09

3. A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis;OncoTargets and Therapy;2024-08

4. The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature;Monaldi Archives for Chest Disease;2024-07-26

5. Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer;BMC Cancer;2024-05-07